Ulcerative Colitis

A global study conducted by 50 different research centers has discovered hundreds of genes that cause five common, hard-to-treat inflammatory diseases

Despite green tea’s many health benefits, combining it with dietary iron does not produce any benefits for inflammatory bowel disease (IBD) patients.

A more effective treatment for Clostridium difficile (C. diff), or hospital-acquired diarrhea, may be on the horizon.

Migraine and tension headaches potentially share genetic links with irritable bowel syndrome (IBS).

Vinegar, the quintessential kitchen staple, has been proven beneficial for patients suffering from ulcerative colitis (UC).

It has long been understood that administering antibiotics to children early on is linked to higher risks of obesity and immune-mediated diseases like inflammatory bowel disease (IBD) and asthma.

An inaugural trial using “smart†pills that measured intestinal gases inside a patient’s body showed favorable results and revealed ways in which fiber affects the gut.

Controlling the levels of specific gut bacteria could be useful in preventing severe diarrhea, according to findings published in the journal Microbiome.

Blood analysis in patients with inflammatory rheumatic diseases such as psoriatic arthritis indicates that biologic medications do not reduce the efficacy of anti-pneumococcal polysaccharide vaccine, and that patients with such conditions may not need to be vaccinated more frequently than others.

Peppermint oil is the latest irritable bowel syndrome (IBS) treatment recommended by gastrointestinal specialists.

Intestinal transplantation can be the last resort for patients suffering from intestinal failure or other difficult conditions. Finding ways to make the procedure more effective can help more patients return to a higher quality of life.

Patients suffering from irritable bowel syndrome (IBS) can reduce their symptoms with the substance ebastine found in histamines used to treat hay fever.

Processed, industrial foods are associated with an increased risk of development of autoimmune diseases such as inflammatory bowel disease (IBD).

Chromoendoscopy trumps random biopsy or white-light colonoscopy as a method for discovering dysplasia in inflammatory bowel diseases (IBD) patients.

Individualized medicine is a growing trend in health care and is making its way into the field of gastroenterology. Doctors are now looking to find treatments that not only work best for their patients but will also be easy for them to follow long term.

Adults afflicted with irritable bowel syndrome (IBS) and other gastrointestinal symptoms can benefit both short- and long-term from psychological therapies.

As a nonprofit organization OpenBiome is becoming one of the leaders in fecal microbiota transplantation technology and also working to boost other areas of public health as well.

Anti-inflammatory treatment for children’s Crohn’s disease alters the components of their gut microbiome but does not fully restore the microbial balance.

Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.

There is growing clinical evidence that inflammatory bowel disease (IBD) can have significant pulmonary manifestations and may be more effectively treated with a multi-specialty approach.

Researchers have found that low and high doses of the experimental immunotherapy drug ozanimod achieve better results than placebo for patients with ulcerative colitis.

People suffering from irritable bowel syndrome (IBS) also often have lower levels of vitamin D.

The US Food and Drug Administration recently approved the Fenix Continence Restoration System for the treatment of fecal incontinence for patients who have tried and failed other medical and surgical options.

Collaboration between gastroenterologists and pathologists is essential in arriving at an accurate diagnosis for precursor lesions in inflammatory bowel disease (IBD) patients.

Colonoscopy patients often don’t accurately recall pertinent details of their exam over time, according to study results presented at the 2015 Clinical Congress of the American College of Surgeons in October.

Many guidelines recommend transfusion if the patient's hemoglobin (Hb) level falls to 7 to 8 g/dL, but some researchers think that using a fixed trigger point may be deleterious to patients.

Marla Dubinsky, MD, Mount Sinai Hospital, reviewed some of the more common side effects associated with the more common therapies that most IBD experts discuss.

Marla Dubinsky, MD, Mount Sinai Hospital, discussed at the 2015 Advances in Inflammatory Bowel Diseases Annual meeting the various levels involved with the relationship between prevention and management in pediatric IBD.

Global pharmaceutical company Allergan announced today the availability by prescription of Viberzi (eluxadoline), their first-in-class treatment for adult patients suffering from irritable bowel syndrome with diarrhea (IBS-D).

Francisco Sylvester, MD, UNC School of medicine emphasized the importance of applying study findings to early interventions in treatment.